Kura Oncology, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $27.4M | $534.1M | $90.7M |
| FY2022 | $36.0M | $456.3M | $51.8M |
| FY2023 | $51.7M | $448.9M | $37.3M |
| FY2024 | $346.5M | $760.2M | $224.5M |
| FY2025 | $564.2M | $738.4M | $149.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $27.4M | $534.1M | $90.7M |
| FY2022 | $36.0M | $456.3M | $51.8M |
| FY2023 | $51.7M | $448.9M | $37.3M |
| FY2024 | $346.5M | $760.2M | $224.5M |
| FY2025 | $564.2M | $738.4M | $149.1M |